Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Harvard Business School
AstraZeneca
Covington
Merck
Federal Trade Commission
Fuji
Deloitte

Generated: April 22, 2018

DrugPatentWatch Database Preview

VINORELBINE TARTRATE Drug Profile

« Back to Dashboard

Which patents cover Vinorelbine Tartrate, and when can generic versions of Vinorelbine Tartrate launch?

Vinorelbine Tartrate is a drug marketed by Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int. and is included in ten NDAs.

The generic ingredient in VINORELBINE TARTRATE is vinorelbine tartrate. There are fifteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the vinorelbine tartrate profile page.
Drug patent expirations by year for VINORELBINE TARTRATE
Pharmacology for VINORELBINE TARTRATE
Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Synonyms for VINORELBINE TARTRATE
125317-39-7
C45H54N4O8.2C4H6O6
CAS-125317-39-7
CHEMBL538943
CV0016
DSSTox_CID_27802
DSSTox_GSID_47825
DSSTox_RID_82572
DTXSID5047825
H847
KB-276096
MolPort-003-986-338
Navelbine
NCGC00165966-02
NCGC00263568-01
SCHEMBL4764
TL8000651
Tox21_112271
Tox21_112271_1
Vinorelbine bitartate
vinorelbine ditartate

US Patents and Regulatory Information for VINORELBINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Totowa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078011-001 Jul 22, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 200148-001 Aug 31, 2012 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076849-001 Apr 18, 2005 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076028-001 Feb 3, 2003 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Dow
AstraZeneca
Cerilliant
QuintilesIMS
Teva
Cantor Fitzgerald
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.